Arnon P. Kater, Yanwen Jiang, Brenda Chyla and John F. Seymour (2020) “Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab”, Haematologica. Pavia, Italy, 105(7), pp. e382-e383. doi: 10.3324/haematol.2020.253849.